Cargando…

A new pathogenic mutation of the BRCA1 gene in a patient with ovarian cancer: A case report

RATIONALE: The breast cancer susceptibility gene (BRCA) is an important tumor suppressor gene and tumor susceptibility gene. Germ line BRCA1/2 mutations significantly increase the risk of breast cancer and other cancers in women. PATIENT CONCERNS: A 48-year-old woman was diagnosed with breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yizhen, Niu, Kemin, Li, Qingli, Li, Danqing, Wang, Rutie, Yin, Liang, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160123/ https://www.ncbi.nlm.nih.gov/pubmed/30235698 http://dx.doi.org/10.1097/MD.0000000000012371

Ejemplares similares

Human papillomavirus subtypes distribution among 2309 cervical cancer patients in West China
por: Li, Kemin, et al.
Publicado: (2017)

Analysis of HPV distribution in patients with cervical precancerous lesions in Western China
por: Li, Kemin, et al.
Publicado: (2017)

Clinical analysis of neoadjuvant chemotherapy in patients with advanced vulvar cancer: A STROBE-compliant article
por: Niu, Yizhen, et al.
Publicado: (2018)

Resistance to PARP Inhibitors After First-Line Platinum-Based Chemotherapy in a Patient with Advanced Ovarian Cancer with a Pathogenic Somatic BRCA1 Mutation
por: Zhong, Lan, et al.
Publicado: (2023)

Choriocarcinoma with brain metastasis after term pregnancy: A case report
por: Song, Liang, et al.
Publicado: (2018)

BRCA Variants Do Not Increase the Risk of Adverse Reactions in Patients With Ovarian Cancer: A Single-Center Real-World Study
por: Li, Kemin, et al.
Publicado: (2022)

Three primary synchronous malignancies of the uterus, cervix, and fallopian tube: A case report
por: Song, Liang, et al.
Publicado: (2018)

Frailty and long-term survival of patients with ovarian cancer: A systematic review and meta-analysis
por: Li, Kemin, et al.
Publicado: (2022)

Primary yolk sac tumor originating from the endometrium: A case report and literature review
por: Song, Liang, et al.
Publicado: (2019)

Hepatic toxicity following actinomycin D chemotherapy in treatment of familial gestational trophoblastic neoplasia: A case report
por: Mu, Xiyan, et al.
Publicado: (2018)

Repeat Cytology and Human Papillomavirus Screening Strategies in Detecting Preinvasive Cervical Lesions
por: Li, Kemin, et al.
Publicado: (2015)

Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family
por: Liao, Ying, et al.
Publicado: (2020)

Monotherapy for low-risk gestational trophoblastic neoplasia with score 5-6
por: Kemin, Li, et al.
Publicado: (2022)

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
por: NOVAKOVIĆ, SRDJAN, et al.
Publicado: (2012)

Different dose series of human papillomavirus vaccine in young females: a pair-wise meta-analysis and network meta-analysis from randomized controlled trials
por: Kemin, Li, et al.
Publicado: (2023)

Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review
por: Hu, Shiqi, et al.
Publicado: (2023)

A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis
por: Liu, Yaxin, et al.
Publicado: (2023)

Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations
por: Birkbak, Nicolai Juul, et al.
Publicado: (2013)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
por: Manchana, Tarinee, et al.
Publicado: (2020)

The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
por: C.E, Drechsel Katja, et al.
Publicado: (2022)

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
por: Osman, K., et al.
Publicado: (2023)

A missense mutation in the BRCA2 gene in three siblings with ovarian cancer.
por: Roth, S., et al.
Publicado: (1998)

Mutational Analysis of BRCA1 Gene in Ovarian and Breast‐ovarian Cancer Families in Japan
por: Takano, Masashi, et al.
Publicado: (1997)

Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival
por: Biglia, Nicoletta, et al.
Publicado: (2016)

Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer
por: Buleje, Jose, et al.
Publicado: (2017)

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
por: Maksimenko, J., et al.
Publicado: (2018)

Ovarian Cancer With Breast Metastasis and Two Pathogenic Variants of BRCA1 Gene
por: Kowsarnia, Saeedeh, et al.
Publicado: (2021)

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
por: O’Mahony, Denise G., et al.
Publicado: (2023)

BRCA mutations in the manifestation and treatment of ovarian cancer
por: Pan, Zimin, et al.
Publicado: (2017)

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
por: Arakelyan, Arsen, et al.
Publicado: (2021)

BRCA1 and BRCA2 Gene Mutations in Breast/Ovarian Cancer Patients from Central and Southern Italy
por: Ottini, Laura, et al.
Publicado: (1999)

New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes
por: Vergote, I, et al.
Publicado: (2016)

Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study
por: Wu, Xiaohua, et al.
Publicado: (2022)

Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil
por: Cotrim, Deborah Porto, et al.
Publicado: (2019)

BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype
por: Zuntini, Roberta, et al.
Publicado: (2017)

The prognostic factor for recurrence in advanced-stage high-grade serous ovarian cancer after complete clinical remission: a nested case-control study
por: Wang, Qiao, et al.
Publicado: (2021)

Predicting Ovarian/Breast Cancer Pathogenic Risks of Human BRCA1 Gene Variants of Unknown Significance
por: Lin, Hui-Heng, et al.
Publicado: (2021)

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
por: Maistro, Simone, et al.
Publicado: (2016)

BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: update
por: Savanevich, Alena, et al.
Publicado: (2021)

BRCA1-mutated ovarian cancer with skin metastasis: a case report
por: Oh, So Ra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_75qes364l2p6msbf4tr7bpk1uj